Popular media and scientific fora are abuzz with news of new clinical techniques, particularly genomic technologies that can provide more targeted approaches to cancer treatment.
In this complex area of ethical and scientific development, there is much evidence about the importance of engaging the public before these techniques become even more well-established, to minimise the risk of misinformation and manage expectations.
Hear from Professor Rachel Ankeny as she presents on a range of issues associated with the public understanding of genomic technologies. She will focus on the potential ethical conflicts of these technologies and the need to learn lessons from past mistakes to anticipate and respond to public reaction in a thoughtful and productive manner.
Professor Rachel A. Ankeny
Professor Rachel Ankeny is Professor of History and Philosophy and Deputy Dean Research in the Faculty of Arts at the University of Adelaide. Her research crosses several fields including bioethics, public understanding of science, and history and philosophy of the biological and biomedical sciences. She has written on a range of topics including public understanding and reception of emerging technologies such as genetic and stem cell technologies, and uses and limitations of animal research models.
Can't attend in person? Register for Webinar
For more information, please see https://researchers.adelaide.edu.au/profile/rachel.ankeny
LinkedIn: Rachel Ankeny